Concept information
Término preferido
sarilumab
Definición
- Sarilumab (trade name Kevzara) is a human monoclonal antibody against the interleukin-6 receptor. Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017. (Wikipedia)
Concepto genérico
Creador
- Patricia Fener
En otras lenguas
-
francés
-
KEVZARA®
URI
http://data.loterre.fr/ark:/67375/C0X-R1C9DXM5-H
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}